AscellaHealth

Payers are creating more aggressive incentives for patients who switch prescriptions, including offering debit cards.

Read more about these incentive programs encouraging patients to switch prescriptions, in an article from Radar on Specialty Pharmacy featuring insights from AscellaHealth’s President and CEO, Dea Belazi: https://lnkd.in/d8k_4y5

www.ascellahealth.com

The world’s most expensive drug, Zolgensma, comes at the price of $2.125 million. Zolgensma treats an ultra-rare disease that less than 20 patients per million will experience. Read more about ultra-rare diseases and their pricey treatments in our latest PM360 article, here:

The World’s Most Expensive Drug Priced at a staggering $2.125 million per patient, Zolgensma is now the world’s most expensive medication. Nevertheless, this one-dose gene ...

At this year’s 6th Annual Cain Brothers Healthcare Conference, AscellaHealth will be showcasing our model that ensures drug safety, payment within approved terms and management of the increasingly complex interactions from prescription to outcome measurement. AscellaHealth also utilizes competitive strategies surrounding value-based service and pricing.

To learn more, view our latest press release here: https://bwnews.pr/2P2gmcG